{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:22:20Z","timestamp":1774462940073,"version":"3.50.1"},"reference-count":184,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100019693","name":"Universidade Federal da Fronteira Sul","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.neuroscience.2022.12.007","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T12:11:25Z","timestamp":1670933485000},"page":"110-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Action of the Purinergic and Cholinergic Anti-inflammatory Pathways on Oxidative Stress in Patients with Alzheimer\u2019s Disease in the Context of the COVID-19 Pandemic"],"prefix":"10.1016","volume":"512","author":[{"given":"J\u00falia L.B.","family":"Sim\u00f5es","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leilane D.","family":"Sobierai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inay\u00e1 F.","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam V.R.","family":"Dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Victor","family":"Coiado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarete D.","family":"Bagatini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuroscience.2022.12.007_b0005","article-title":"The pleiotropic role of p53 in functional\/dysfunctional neurons: focus on pathogenesis and diagnosis of Alzheimer\u2019s disease","volume":"12","author":"Abate","year":"2020","journal-title":"Alzheimer\u2019s Res Therapy"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.12.007_b0010","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s12035-013-8577-5","article-title":"Loss of P2Y2 Nucleotide Receptors Enhances Early Pathology in the TgCRND8 Mouse Model of Alzheimer\u2019s Disease","volume":"49","author":"Ajit","year":"2014","journal-title":"Mol Neurobiol"},{"issue":"7","key":"10.1016\/j.neuroscience.2022.12.007_b0015","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/jgs.16536","article-title":"A Unique Presentation of Delirium in a Patient with Otherwise Asymptomatic COVID-19","volume":"68","author":"Alkeridy","year":"2020","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"10.1016\/j.neuroscience.2022.12.007_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071595","article-title":"Microglia Purinoceptor P2Y6: An Emerging Therapeutic Target in CNS Diseases","volume":"9","author":"Anwar","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.12.007_b0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5114\/fn.2019.85929","article-title":"Risk factors for Alzheimer\u2019s disease","volume":"57","author":"Armstrong","year":"2019","journal-title":"Folia Neuropathol"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.12.007_b0030","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jhep.2020.09.031","article-title":"COVID-19: Discovery, diagnostics and drug development","volume":"74","author":"Asselah","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fcvm.2018.00107","article-title":"Genetic Alterations in Oxidant and Anti-Oxidant Enzymes in the Vascular System","author":"Awad","year":"2018","journal-title":"Front Cardiovasc Med"},{"issue":"7","key":"10.1016\/j.neuroscience.2022.12.007_b0040","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/acschemneuro.0c00122","article-title":"Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms","volume":"11","author":"Baig","year":"2020","journal-title":"ACS Chem Nerosci"},{"issue":"4","key":"10.1016\/j.neuroscience.2022.12.007_b0045","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0092-8674(94)90498-7","article-title":"Galectins: a family of animal beta-galactoside-binding lectins","volume":"76","author":"Barondes","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0050","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/271813","article-title":"\u2018P2X7 Receptor Activation Induces Reactive Oxygen Species Formation and Cell Death in Murine EOC13 Microglia","volume":"2013","author":"Bartlett","year":"2013","journal-title":"Mediat Inflamm"},{"issue":"4","key":"10.1016\/j.neuroscience.2022.12.007_b0055","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1139\/gen-2020-0124","article-title":"Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus 1","volume":"64","author":"Beacon","year":"2021","journal-title":"Genome"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.12.007_b0060","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3233\/JAD-170680","article-title":"Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer\u2019s Disease Diagnosis","volume":"62","author":"Bjerke","year":"2018","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.12.007_b0065","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/path.5471","article-title":"Angiotensin-converting enzyme-2 (ACE2), SARS-CoV-2 and pathophysiology of coronavirus disease 2019 (COVID-19)","volume":"251","author":"Bourgonje","year":"2020","journal-title":"J Pathol"},{"issue":"10","key":"10.1016\/j.neuroscience.2022.12.007_b0070","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1113\/JP275101","article-title":"Molecular function of \u03b17 nicotinic receptors as drug targets","volume":"596","author":"Bouzat","year":"2018","journal-title":"J Physiol"},{"issue":"10","key":"10.1016\/j.neuroscience.2022.12.007_b0075","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.mad.2013.08.005","article-title":"Epigenetic changes in the progression of Alzheimer\u2019s disease","volume":"134","author":"Bradley-Whitman","year":"2013","journal-title":"Mech Ageing Dev"},{"issue":"4","key":"10.1016\/j.neuroscience.2022.12.007_b0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrn3710","article-title":"Microglial phagocytosis of live neurons","volume":"15","author":"Brown","year":"2014","journal-title":"Nat Rev Neurosci"},{"issue":"Suplemento COVID","key":"10.1016\/j.neuroscience.2022.12.007_b0085","first-page":"086","article-title":"COVID-19 from a cardiovascular perspective","volume":"91","author":"Bryce-Moncloa","year":"2021","journal-title":"Archivos de cardiologia de Mexico"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-9717-6_1","article-title":"Introduction to Purinergic Signaling","volume":"2041","author":"Burnstock","year":"2020","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0095","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fncel.2021.645244","article-title":"The P2X7 Receptor in Microglial Cells Modulates the Endolysosomal Axis, Autophagy, and Phagocytosis","volume":"15","author":"Campagno","year":"2021","journal-title":"Front Cell Neurosci"},{"issue":"31","key":"10.1016\/j.neuroscience.2022.12.007_b0100","doi-asserted-by":"crossref","first-page":"12569","DOI":"10.1523\/JNEUROSCI.1251-13.2013","article-title":"p63 Regulates Adult Neural Precursor and Newly Born Neuron Survival to Control Hippocampal-Dependent Behavior","volume":"33","author":"Cancino","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0105","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neubiorev.2014.02.010","article-title":"Familial Alzheimer\u2019s disease sustained by presenilin 2 mutations: systematic review of literature and genotype-phenotype correlation","volume":"42","author":"Canevelli","year":"2014","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.814999","article-title":"Microglial Activation Modulated by P2X4R in Ischemia and Repercussions in Alzheimer\u2019s Disease","volume":"13","author":"Castillo","year":"2022","journal-title":"Front Physiol"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.12.007_b0115","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001424","article-title":"Manipulation of ACE2 expression in COVID-19","volume":"7","author":"Chaudhry","year":"2020","journal-title":"Open Heart"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.682603","article-title":"Coronavirus, the King Who Wanted More Than a Crown: From Common to the Highly Pathogenic SARS-CoV-2, Is the Key in the Accessory Genes?","volume":"12","author":"Chazal","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0125","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","article-title":"Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease","volume":"14","author":"Cheignon","year":"2018","journal-title":"Redox Biol"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.12.007_b0140","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12264-013-1423-y","article-title":"Oxidative stress in Alzheimer\u2019s disease","volume":"30","author":"Chen and Zhong","year":"2014","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuroscience.2014.08.036","article-title":"Brilliant Blue G improves cognition in an animal model of Alzheimer\u2019s disease and inhibits amyloid-\u03b2-induced loss of filopodia and dendrite spines in hippocampal neurons","volume":"279","author":"Chen","year":"2014","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.neuroscience.2022.12.007_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27061816","article-title":"Role of Cholinergic Signaling in Alzheimer\u2019s Disease","volume":"27","author":"Chen","year":"2022","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"4","key":"10.1016\/j.neuroscience.2022.12.007_b0145","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11302-018-9629-0","article-title":"Role of purinergic receptors in the Alzheimer\u2019s disease","volume":"14","author":"Cie\u015blak","year":"2018","journal-title":"Purinergic Signalling"},{"issue":"6","key":"10.1016\/j.neuroscience.2022.12.007_b0150","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.23812\/20-1-E","article-title":"Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy","volume":"34","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"issue":"1\u20133","key":"10.1016\/j.neuroscience.2022.12.007_b0155","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000295663","article-title":"Treatment of Alzheimer\u2019s disease with a cholinesterase inhibitor combined with antioxidants","volume":"7","author":"Cornelli","year":"2010","journal-title":"Neurodegener Dis"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.12.007_b0160","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/joim.13006","article-title":"Beyond neurotransmission: acetylcholine in immunity and inflammation","volume":"287","author":"Cox","year":"2020","journal-title":"J Intern Med"},{"issue":"11","key":"10.1016\/j.neuroscience.2022.12.007_b0165","doi-asserted-by":"crossref","first-page":"972","DOI":"10.2174\/1567205017666201130092427","article-title":"The Association between TNF-alpha, IL-1 alpha and IL-10 with Alzheimer\u2019s Disease","volume":"17","author":"Culjak","year":"2020","journal-title":"Curr Alzheimer Res"},{"issue":"7","key":"10.1016\/j.neuroscience.2022.12.007_b9015","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.bjp.0705185","article-title":"Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity","volume":"138","author":"Dall'Igna","year":"2003","journal-title":"Br J Pharmacol."},{"issue":"5","key":"10.1016\/j.neuroscience.2022.12.007_b0170","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1590\/S0101-60832009000500004","article-title":"Papel da prote\u00edna Tau na fisiopatologia da dem\u00eancia frontotemporal","volume":"36","author":"de Paula","year":"2009","journal-title":"Archiv Clin Psychiatry (S\u00e3o Paulo)"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.12.007_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms6422","article-title":"Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in vivo in an Alzheimer\u2019s disease mouse model","volume":"5","author":"Delekate","year":"2014","journal-title":"Nature Commun"},{"issue":"4","key":"10.1016\/j.neuroscience.2022.12.007_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.00028-20","article-title":"Coronavirus disease 2019\u2013COVID-19","volume":"33","author":"Dhama","year":"2020","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.12.007_b0185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tins.2008.11.003","article-title":"Purinergic signalling in inflammation of the central nervous system","volume":"32","author":"Di Virgilio","year":"2009","journal-title":"Trends Neurosci"},{"issue":"8","key":"10.1016\/j.neuroscience.2022.12.007_b0190","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.neurobiolaging.2011.09.040","article-title":"In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer\u2019s disease through GSK3\u03b2 and secretases","volume":"33","author":"Diaz-Hernandez","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0195","article-title":"Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer\u2019s Disease","volume":"2015","author":"Dong","year":"2015","journal-title":"Disease Mark"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.12.007_b0200","doi-asserted-by":"crossref","DOI":"10.15761\/JTS.1000397","article-title":"Proposed mechanism for anosmia during COVID-19: The role of local zinc distribution","volume":"7","author":"Equils","year":"2021","journal-title":"J Translat Sci"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0205","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainresbull.2018.10.014","article-title":"Purinergic signaling in Alzheimer\u2019s disease","volume":"151","author":"Erb","year":"2019","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2018.00235","article-title":"Beneficial effect of a selective adenosine A2A receptor antagonist in the APPswe\/PS1dE9 mouse model of Alzheimer\u2019s disease","volume":"11","author":"Faivre","year":"2018","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.12.007_b0220","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-020-01012-6","article-title":"P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer\u2019s disease","volume":"8","author":"Farmer","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0225","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.toxrep.2020.04.012","article-title":"Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system","volume":"7","author":"Farsalinos","year":"2020","journal-title":"Toxicol Rep"},{"issue":"10","key":"10.1016\/j.neuroscience.2022.12.007_b0230","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1212\/WNL.0000000000009058","article-title":"Biological subtypes of Alzheimer disease: A systematic review and meta-analysis","volume":"94","author":"Ferreira","year":"2020","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.12.007_b0235","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer\u2019s disease: Targeting the Cholinergic System","volume":"14","author":"Ferreira-Vieira","year":"2016","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.12.007_b0240","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12250-020-00207-4","article-title":"Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools","volume":"35","author":"Fu","year":"2020","journal-title":"Virol Sin"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.12.007_b0245","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/glia.20749","article-title":"P2Y1 receptor signaling enhances neuroprotection by astrocytes against oxidative stress via IL-6 release in hippocampal cultures","volume":"57","author":"Fujita","year":"2009","journal-title":"Glia"},{"issue":"4\u20135","key":"10.1016\/j.neuroscience.2022.12.007_b0215","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jmb.2012.01.006","article-title":"Oligomeric intermediates in amyloid formation: structure determination and mechanisms of toxicity","volume":"421","author":"F\u00e4ndrich,","year":"2012","journal-title":"J Mol Biol"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.12.007_b0250","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1590\/S0101-60832005000300004","article-title":"Diagn\u00f3stico diferencial das dem\u00eancias","volume":"32","author":"Gallucci Neto","year":"2005","journal-title":"Archiv Clin Psychiatry (S\u00e3o Paulo)"},{"issue":"10","key":"10.1016\/j.neuroscience.2022.12.007_b0255","doi-asserted-by":"crossref","first-page":"175","DOI":"10.21037\/atm.2018.04.23","article-title":"Tau in neurodegenerative disease","volume":"6","author":"Gao","year":"2018","journal-title":"Ann Translat Med"},{"issue":"10062","key":"10.1016\/j.neuroscience.2022.12.007_b0260","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1016\/S0140-6736(16)31275-2","article-title":"Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer\u2019s disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial","volume":"388","author":"Gauthier","year":"2016","journal-title":"Lancet (London, England)"},{"issue":"7","key":"10.1016\/j.neuroscience.2022.12.007_b0265","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1093\/brain\/awac096","article-title":"Reimagining cholinergic therapy for Alzheimer\u2019s disease","volume":"145","author":"Giacobini","year":"2022","journal-title":"Brain J Neurol"},{"issue":"6311","key":"10.1016\/j.neuroscience.2022.12.007_b0270","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease","volume":"349","author":"Goate","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0275","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01330","article-title":"Exploring the Role of P2X Receptors in Alzheimer\u2019s Disease","volume":"10","author":"Godoy","year":"2019","journal-title":"Front Pharmacol"},{"issue":"6248","key":"10.1016\/j.neuroscience.2022.12.007_b0280","doi-asserted-by":"crossref","DOI":"10.1126\/science.1255555","article-title":"NEURODEGENERATION. Alzheimer\u2019s and Parkinson\u2019s diseases: The prion concept in relation to assembled A\u03b2, tau, and \u03b1-synuclein","volume":"349","author":"Goedert","year":"2015","journal-title":"Science (New York, N.Y.)"},{"issue":"5","key":"10.1016\/j.neuroscience.2022.12.007_b0285","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.bbamem.2010.12.001","article-title":"Adenosine receptors and brain diseases: Neuroprotection and neurodegeneration","volume":"1808","author":"Gomes","year":"2011","journal-title":"Biochimica et Biophysica Acta (BBA) \u2013 Biomembranes"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0295","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3389\/fmed.2020.00506","article-title":"Purinergic System Signaling in Metainflammation-Associated Osteoarthritis","volume":"7","author":"Gratal","year":"2020","journal-title":"Front Med"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.12.007_b0290","article-title":"Thrombosis and Coagulopathy in COVID-19","volume":"46","author":"G\u00f3mez-Mesa","year":"2021","journal-title":"Curr Problems Cardiol"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.12.007_b0300","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0305","series-title":"Brain","first-page":"1917","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease","author":"Hampel","year":"2018"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0310","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science (New York, N.Y.)"},{"issue":"6","key":"10.1016\/j.neuroscience.2022.12.007_b0315","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrn3880","article-title":"Immune attack: The role of inflammation in Alzheimer disease","volume":"16","author":"Heppner","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.05.002","article-title":"Cholinergic Modulation of the Immune System Presents New Approaches for Treating Inflammation","volume":"179","author":"Hoover","year":"2017","journal-title":"Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.12.007_b0325","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/ntr\/nty116","article-title":"Nicotinic Acetylcholine Receptor Agonists for the Treatment of Alzheimer\u2019s Dementia: An Update","volume":"21","author":"Hoskin","year":"2019","journal-title":"Nicotine Tob Res"},{"issue":"8","key":"10.1016\/j.neuroscience.2022.12.007_b0330","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2174\/156802611795347654","article-title":"The role of adenosine in the regulation of sleep","volume":"11","author":"Huang","year":"2011","journal-title":"Curr Top Med Chem"},{"issue":"8","key":"10.1016\/j.neuroscience.2022.12.007_b0335","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/jcbfm.2013.76","article-title":"The APOE \u025b4\/\u025b4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer\u2019s disease patients","volume":"33","author":"Hultman","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.12.007_b0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151081","article-title":"Periodontitis and Cognitive Decline in Alzheimer\u2019s Disease","volume":"11","author":"Ide","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0345","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neurobiolaging.2021.07.014","article-title":"Emerging roles of oxidative stress in brain aging and Alzheimer\u2019s disease","volume":"107","author":"Ionescu-Tucker","year":"2021","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0350","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbadis.2004.09.008","article-title":"Tau pathology in Alzheimer disease and other tauopathies","author":"Iqbal","year":"2005","journal-title":"Biochimica et Biophysica Acta \u2013 Mol Basis Dis"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.12.007_b0355","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s12035-014-9053-6","article-title":"Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer\u2019s Disease: Understanding the Therapeutics Strategies","volume":"53","author":"Kamat","year":"2016","journal-title":"Mol Neurobiol"},{"issue":"6","key":"10.1016\/j.neuroscience.2022.12.007_b0360","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neurobiolaging.2004.08.011","article-title":"Oxidative state in platelets and erythrocytes in aging and Alzheimer\u2019s disease","volume":"26","author":"Kawamoto","year":"2005","journal-title":"Neurobiol Aging"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.12.007_b0365","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1523\/JNEUROSCI.4849-06.2007","article-title":"Abeta40 inhibits amyloid deposition in vivo","volume":"27","author":"Kim","year":"2007","journal-title":"J Neurosci: Off J Soc Neurosci"},{"issue":"6","key":"10.1016\/j.neuroscience.2022.12.007_b0375","first-page":"3701","article-title":"Uridine 5\u2019-diphosphate induces chemokine expression in microglia and astrocytes through activation of the P2Y6 receptor","volume":"186","author":"Kim","year":"2011","journal-title":"J Immunol (Baltimore, Md.\u00a0: 1950)"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.12.007_b0370","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1471-4159.2012.07700.x","article-title":"Nucleotides released from A\u03b21-42 -treated microglial cells increase cell migration and A\u03b21-\u2084\u2082 uptake through P2Y\u2082 receptor activation","volume":"121","author":"Kim","year":"2012","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.neuroscience.2022.12.007_b0380","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3390\/v7052358","article-title":"Genomic Analysis of 15 Human Coronaviruses OC43 (HCoV-OC43s) Circulating in France from 2001 to 2013 Reveals a High Intra-Specific Diversity with New Recombinant Genotypes","volume":"7","author":"Kin","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0385","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuroimage.2019.05.044","article-title":"Cholinergic and serotonergic modulation of resting state functional brain connectivity in Alzheimer\u2019s disease","volume":"199","author":"Klaassens","year":"2019","journal-title":"Neuroimage"},{"issue":"7139","key":"10.1016\/j.neuroscience.2022.12.007_b0390","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/nature05704","article-title":"UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis","volume":"446","author":"Koizumi","year":"2007","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.neuroscience.2022.12.007_b0395","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1471-4159.2009.06048.x","article-title":"IL-1\u03b2 enhances nucleotide-induced and \u03b1-secretase-dependent app processing in rat primary cortical neurons via upregulation of the P2Y2 receptor","volume":"109","author":"Kong","year":"2009","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.neuroscience.2022.12.007_b0400","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1471-4159.2009.06048.x","article-title":"Interleukin-1beta enhances nucleotide-induced and alpha-secretase-dependent amyloid precursor protein processing in rat primary cortical neurons via up-regulation of the P2Y(2) receptor","volume":"109","author":"Kong","year":"2009","journal-title":"J Neurochem"},{"issue":"52","key":"10.1016\/j.neuroscience.2022.12.007_b0405","doi-asserted-by":"crossref","first-page":"14442","DOI":"10.1523\/JNEUROSCI.4104-07.2007","article-title":"Focusing effect of acetylcholine on neuroplasticity in the human motor cortex","volume":"27","author":"Kuo","year":"2007","journal-title":"J Neurosci: Off J Soc Neurosci"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.12.007_b0410","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/mp.2014.151","article-title":"A2A adenosine receptor deletion is protective in a mouse model of Tauopathy","volume":"21","author":"Laurent","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0420","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.7638622","article-title":"Candidate gene for the chromosome 1 familial Alzheimer\u2019s disease locus","volume":"269","author":"Levy-Lahad","year":"1995","journal-title":"Science (New York, N.Y.)"},{"issue":"14","key":"10.1016\/j.neuroscience.2022.12.007_b0415","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.febslet.2011.05.048","article-title":"Opposite effects of P2X7 and P2Y2 nucleotide receptors on \u03b1-secretase-dependent APP processing in Neuro-2a cells","volume":"585","author":"Le\u00f3n-Otegui","year":"2011","journal-title":"FEBS Lett"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.12.007_b0425","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.jinf.2020.06.072","article-title":"Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer\u2019s disease","volume":"81","author":"Lim","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0430","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bbi.2021.10.014","article-title":"Omega-3 fatty acids and blood-based biomarkers in Alzheimer\u2019s disease and mild cognitive impairment: A randomized placebo-controlled trial","volume":"99","author":"Lin","year":"2022","journal-title":"Brain Behav Immun"},{"issue":"4","key":"10.1016\/j.neuroscience.2022.12.007_b0435","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1042\/BST20170501","article-title":"Mitochondrial abnormalities in Parkinson\u2019s disease and Alzheimer\u2019s disease: can mitochondria be targeted therapeutically?","volume":"46","author":"Macdonald","year":"2018","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.12.007_b0440","article-title":"The cholinergic system in subtypes of Alzheimer\u2019s disease: an in vivo longitudinal MRI study","volume":"12","author":"MacHado","year":"2020","journal-title":"Alzheimer\u2019s Res Therapy"},{"issue":"11","key":"10.1016\/j.neuroscience.2022.12.007_b0445","doi-asserted-by":"crossref","DOI":"10.2174\/1567205014666170203125942","article-title":"Biomarkers for Alzheimer\u2019s Disease Diagnosis","volume":"14","author":"Mantzavinos","year":"2017","journal-title":"Curr Alzheimer Res"},{"issue":"8","key":"10.1016\/j.neuroscience.2022.12.007_b0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11882-018-0796-4","article-title":"Olfactory Dysfunction in Neurodegenerative Diseases","volume":"18","author":"Marin","year":"2018","journal-title":"Curr Allergy Asthma Rep"},{"issue":"6","key":"10.1016\/j.neuroscience.2022.12.007_b0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.neuroscience.2022.12.007_b0460","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1097\/01.jnen.0000240470.97295.d3","article-title":"Upregulated expression of purinergic P2X(7) receptor in Alzheimer disease and amyloid-beta peptide-treated microglia and in peptide-injected rat hippocampus","volume":"65","author":"McLarnon","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"10.1016\/j.neuroscience.2022.12.007_b0465","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00702-017-1732-9","article-title":"The IL-1\u03b2 phenomena in neuroinflammatory diseases","volume":"125","author":"Mendiola","year":"2018","journal-title":"J Neural Transmiss (Vienna, Austria\u00a0: 1996)"},{"key":"10.1016\/j.neuroscience.2022.12.007_b9005","series-title":"Treasure Island (FL): StatPearls Publishing; 2022 Jan","article-title":"Physiology, Anticholinergic Reaction","author":"Migirov","year":"2022"},{"issue":"4","key":"10.1016\/j.neuroscience.2022.12.007_b0470","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1242\/dev.02233","article-title":"Extracellular nucleotide signaling in adult neural stem cells: synergism with growth factor-mediated cellular proliferation","volume":"133","author":"Mishra","year":"2006","journal-title":"Development"},{"issue":"8","key":"10.1016\/j.neuroscience.2022.12.007_b0475","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/alr.22587","article-title":"Smell dysfunction: a biomarker for COVID-19","volume":"10","author":"Moein","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0480","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuropharm.2013.07.017","article-title":"The activation of P2Y6 receptor in cultured spinal microglia induces the production of CCL2 through the MAP kinases-NF-\u03baB pathway","volume":"75","author":"Morioka","year":"2013","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.12.007_b0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-03813-7","article-title":"Neuronal P2X7 receptor-induced reactive oxygen species production contributes to nociceptive behavior in mice","volume":"7","author":"Munoz","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0490","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neulet.2019.04.022","article-title":"The complexity of tau in Alzheimer\u2019s disease","volume":"705","author":"Naseri","year":"2019","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.12.007_b0495","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40478-018-0557-6","article-title":"Phosphorylation of different tau sites during progression of Alzheimer\u2019s disease","volume":"6","author":"Neddens","year":"2018","journal-title":"Acta Neuropathol Commun"},{"issue":"9","key":"10.1016\/j.neuroscience.2022.12.007_b0500","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/glia.22693","article-title":"Inhibition of UDP\/P2Y6 purinergic signaling prevents phagocytosis of viable neurons by activated microglia in vitro and in vivo","volume":"62","author":"Neher","year":"2014","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.12.007_b0505","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30487-6","article-title":"IL-1\u03b2, IL-6, TNF- \u03b1 and CRP in Elderly Patients with Depression or Alzheimer\u2019s disease: Systematic Review and Meta-Analysis","volume":"8","author":"Ng","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0510","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2638130","article-title":"RNA and Oxidative Stress in Alzheimer\u2019s Disease: Focus on microRNAs","volume":"2020","author":"Nunomura","year":"2020","journal-title":"Oxidat Med Cell Longevity"},{"issue":"13","key":"10.1016\/j.neuroscience.2022.12.007_b0520","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1523\/JNEUROSCI.6417-10.2011","article-title":"Amyloid \u03b2-Induced Death in Neurons Involves Glial and Neuronal Hemichannels","volume":"31","author":"Orellana","year":"2011","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.neuroscience.2022.12.007_b0515","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1471-4159.2011.07210.x","article-title":"ATP and glutamate released via astroglial connexin43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels","volume":"118","author":"Orellana","year":"2011","journal-title":"J Neurochem"},{"issue":"16","key":"10.1016\/j.neuroscience.2022.12.007_b0525","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00073-19","article-title":"CKAP4 Regulates Cell Migration via the Interaction with and Recycling of Integrin","volume":"39","author":"Osugi","year":"2019","journal-title":"Mol Cell Biol"},{"issue":"15","key":"10.1016\/j.neuroscience.2022.12.007_b0530","doi-asserted-by":"crossref","first-page":"13309","DOI":"10.1074\/jbc.M209478200","article-title":"P2X7 Mediates Superoxide Production in Primary Microglia and Is Up-regulated in a Transgenic Mouse Model of Alzheimer\u2019s Disease","volume":"278","author":"Parvathenani","year":"2003","journal-title":"J Biol Chem"},{"issue":"2\u20133","key":"10.1016\/j.neuroscience.2022.12.007_b0545","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s12035-010-8115-7","article-title":"P2Y2 nucleotide receptor-mediated responses in brain cells","volume":"41","author":"Peterson","year":"2010","journal-title":"Mol Neurobiol"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.12.007_b0550","doi-asserted-by":"crossref","first-page":"286.e7","DOI":"10.1016\/j.cmi.2020.09.051","article-title":"A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients","volume":"27","author":"Petrone","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"24","key":"10.1016\/j.neuroscience.2022.12.007_b0535","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20246136","article-title":"Oxidative Damage of DNA as Early Marker of Alzheimer\u2019s Disease","volume":"20","author":"Pe\u00f1a-Bautista","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.12.007_b0555","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuron.2012.08.036","article-title":"Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior","volume":"76","author":"Picciotto","year":"2012","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.neuroscience.2022.12.007_b0560","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.bbadis.2018.11.007","article-title":"Functions and dysfunctions of nitric oxide in brain","volume":"1865","author":"Pic\u00f3n-Pag\u00e8s","year":"2019","journal-title":"Biochim Biophys Acta (BBA) \u2013 Mol Basis Dis"},{"issue":"5","key":"10.1016\/j.neuroscience.2022.12.007_b0565","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2174\/1567205016666190321163438","article-title":"Therapeutic Strategies Targeting Amyloid-\u03b2 in Alzheimer\u2019s Disease","volume":"16","author":"Pinheiro","year":"2019","journal-title":"Curr Alzheimer Res"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.12.007_b0570","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1148\/radiol.2020201187","article-title":"COVID-19\u2013associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features","volume":"296","author":"Poyiadji","year":"2020","journal-title":"Radiology"},{"issue":"13","key":"10.1016\/j.neuroscience.2022.12.007_b0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110148","article-title":"The microglial P2Y6 receptor mediates neuronal loss and memory deficits in neurodegeneration","volume":"37","author":"Puigdell\u00edvol","year":"2021","journal-title":"Cell Rep"},{"issue":"22","key":"10.1016\/j.neuroscience.2022.12.007_b0540","doi-asserted-by":"crossref","first-page":"11603","DOI":"10.1093\/nar\/gks903","article-title":"Regulation of human Dicer by the resident ER membrane protein CLIMP-63","volume":"40","author":"P\u00e9pin","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.12.007_b0585","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s12035-020-02177-w","article-title":"Neurobiochemical Cross-talk Between COVID-19 and Alzheimer\u2019s Disease","volume":"58","author":"Rahman","year":"2021","journal-title":"Mol Neurobiol"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.12.007_b0580","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/157015909789152119","article-title":"The Role of Adenosine in Alzheimer\u2019s Disease","volume":"7","author":"Rahman","year":"2009","journal-title":"Curr Neuropharmacol"},{"issue":"5","key":"10.1016\/j.neuroscience.2022.12.007_b0590","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1162\/jocn.2006.18.5.793","article-title":"Combined blockade of cholinergic receptors shifts the brain from stimulus encoding to memory consolidation","volume":"18","author":"Rasch","year":"2006","journal-title":"J Cogn Neurosci"},{"issue":"6","key":"10.1016\/j.neuroscience.2022.12.007_b0595","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1084\/jem.20171487","article-title":"P2Y1 receptor blockade normalizes network dysfunction and cognition in an Alzheimer\u2019s disease model","volume":"215","author":"Reichenbach","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0600","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4155\/fmc-2016-0213","article-title":"Probing the cholinergic system to understand neurodegenerative diseases","author":"Renard","year":"2017","journal-title":"Future Med Chem"},{"issue":"12","key":"10.1016\/j.neuroscience.2022.12.007_b0605","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1164\/rccm.201712-2410OC","article-title":"Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis","volume":"199","author":"Reyfman","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0610","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0079-6123(08)62107-X","article-title":"Purinergic regulation of acetylcholine release","volume":"109","author":"Ribeiro","year":"1996","journal-title":"Prog Brain Res"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.12.007_b0615","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/brain\/awx356","article-title":"Effect of cholinergic treatment depends on cholinergic integrity in early Alzheimer\u2019s disease","volume":"141","author":"Richter","year":"2018","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.12.007_b0620","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00415-005-0926-5","article-title":"Acetylcholine esterase inhibitor donepezil improves dynamic cerebrovascular regulation in Alzheimer patients","volume":"253","author":"Rosengarten","year":"2006","journal-title":"J Neurol"},{"issue":"6 Pt A","key":"10.1016\/j.neuroscience.2022.12.007_b0625","first-page":"1218","article-title":"The role of interleukin-6 signaling in nervous tissue","volume":"1863","author":"Rothaug","year":"2016","journal-title":"BBA"},{"issue":"17","key":"10.1016\/j.neuroscience.2022.12.007_b0630","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/WNR.0b013e3283179333","article-title":"Block of purinergic P2X(7) receptor is neuroprotective in an animal model of Alzheimer\u2019s disease","volume":"19","author":"Ryu","year":"2008","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0635","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejmech.2016.02.065","article-title":"Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches","volume":"114","author":"Salahuddin","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0640","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.613979","article-title":"The Cholinergic Drug Galantamine Alleviates Oxidative Stress Alongside Anti-inflammatory and Cardio-Metabolic Effects in Subjects With the Metabolic Syndrome in a Randomized Trial","volume":"12","author":"Sangaleti","year":"2021","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.neuroscience.2022.12.007_b0645","first-page":"4378","article-title":"Activation of microglia by amyloid beta requires P2X7 receptor expression","volume":"182","author":"Sanz","year":"2009","journal-title":"J Immunol (Baltimore, Md.\u00a0: 1950)"},{"issue":"6","key":"10.1016\/j.neuroscience.2022.12.007_b0655","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"issue":"5300","key":"10.1016\/j.neuroscience.2022.12.007_b0650","first-page":"630","article-title":"Alzheimer\u2019s disease: genotypes, phenotypes, and treatments","volume":"275","author":"Selkoe","year":"1997","journal-title":"Animal"},{"issue":"12","key":"10.1016\/j.neuroscience.2022.12.007_b0660","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.tips.2018.10.001","article-title":"Copper and Zinc Dysregulation in Alzheimer\u2019s Disease","volume":"39","author":"Sensi","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0665","doi-asserted-by":"crossref","unstructured":"Sereniki, A. et al. (2008). A doen\u00e7a de Alzheimer: aspectos fisiopatol\u00f3gicos e farmacol\u00f3gicos Alzheimer\u2019s disease: pathophysiological and pharmacological features.","DOI":"10.1590\/S0101-81082008000200002"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.12.007_b0670","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ajpath.2015.10.010","article-title":"Plaque-Associated Local Toxicity Increases over the Clinical Course of Alzheimer Disease","volume":"186","author":"Serrano-Pozo","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocn.2017.06.074","article-title":"Genetics of Alzheimer\u2019s disease: From pathogenesis to clinical usage","volume":"45","author":"Shao","year":"2017","journal-title":"J Clin Neurosci: Off J Neurosurg Soc Australasia"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0680","first-page":"1479","article-title":"Cholinesterase inhibitors as Alzheimer\u2019s therapeutics (Review)","author":"Sharma","year":"2019","journal-title":"Mol Med Rep"},{"issue":"6534","key":"10.1016\/j.neuroscience.2022.12.007_b0685","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"issue":"7673","key":"10.1016\/j.neuroscience.2022.12.007_b0690","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.neuroscience.2022.12.007_b0695","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/brb3.1145","article-title":"Association of deposition of tau and amyloid-\u03b2 proteins with structural connectivity changes in cognitively normal older adults and Alzheimer\u2019s disease spectrum patients","volume":"8","author":"Shigemoto","year":"2018","journal-title":"Brain Behavior"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.12.007_b0700","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3233\/JAD-130722","article-title":"A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer\u2019s disease","volume":"38","author":"Shinto","year":"2014","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"issue":"13","key":"10.1016\/j.neuroscience.2022.12.007_b0705","article-title":"GISAID: Global initiative on sharing all influenza data - from vision to reality","volume":"22","author":"Shu","year":"2017","journal-title":"Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.12.007_b0710","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11481-020-09980-1","article-title":"Purinergic Signaling of ATP in COVID-19 Associated Guillain-Barr\u00e9 Syndrome","volume":"16","author":"Sim\u00f5es","year":"2021","journal-title":"J Neuroimmune Pharmacol"},{"issue":"8","key":"10.1016\/j.neuroscience.2022.12.007_b0715","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.bbamem.2007.02.002","article-title":"The redox chemistry of the Alzheimer\u2019s disease amyloid \u03b2 peptide","volume":"1768","author":"Smith","year":"2007","journal-title":"Biochimica et Biophysica Acta (BBA) \u2013 Biomembranes"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.12.007_b0720","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12264-012-1057-5","article-title":"Caspase-3 activation as a bifurcation point between plasticity and cell death","volume":"28","author":"Snigdha","year":"2012","journal-title":"Neurosci Bull"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.12.007_b0725","doi-asserted-by":"crossref","DOI":"10.3390\/biom10010040","article-title":"Alzheimer\u2019s Disease Pharmacotherapy in Relation to Cholinergic System Involvement","volume":"10","author":"Stanciu","year":"2019","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.12.007_b0730","doi-asserted-by":"crossref","DOI":"10.3390\/biom10010040","article-title":"Alzheimer\u2019s Disease Pharmacotherapy in Relation to Cholinergic System Involvement","volume":"10","author":"Stanciu","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.12.007_b9000","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00018-021-04062-8","article-title":"Long-term caffeine treatment of Alzheimer mouse models ameliorates behavioural deficits and neuron loss and promotes cellular and molecular markers of neurogenesis","volume":"79","author":"Stazi","year":"2021","journal-title":"Cell Mol Life Sci."},{"issue":"3","key":"10.1016\/j.neuroscience.2022.12.007_b0735","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13473","article-title":"Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19","volume":"229","author":"Steardo","year":"2020","journal-title":"Acta Physiol (Oxford, England)"},{"issue":"6","key":"10.1016\/j.neuroscience.2022.12.007_b0740","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol"},{"issue":"5","key":"10.1016\/j.neuroscience.2022.12.007_b0745","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bj.2017.06.010","article-title":"P2X4: A fast and sensitive purinergic receptor","volume":"40","author":"Suurv\u00e4li","year":"2017","journal-title":"Biomed J"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0750","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/826143","article-title":"Nitro-oxidative stress after neuronal ischemia induces protein nitrotyrosination and cell death","author":"Tajes","year":"2013","journal-title":"Oxidat Med Cell Longevity"},{"issue":"11","key":"10.1016\/j.neuroscience.2022.12.007_b0755","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.jalz.2019.06.4952","article-title":"Differential expression of microRNAs in Alzheimer\u2019s disease brain, blood, and cerebrospinal fluid","volume":"15","author":"Takousis","year":"2019","journal-title":"Alzheimer\u2019s Dementia: J Alzheimer\u2019s Assoc"},{"issue":"10","key":"10.1016\/j.neuroscience.2022.12.007_b0760","doi-asserted-by":"crossref","first-page":"16295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in Inflammation, Immunity, and Disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harbor Perspect Biol"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.12.007_b0765","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41418-019-0348-z","article-title":"Galectin-3 promotes A\u03b2 oligomerization and A\u03b2 toxicity in a mouse model of Alzheimer\u2019s disease","volume":"27","author":"Tao","year":"2020","journal-title":"Cell Death Different"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0770","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jneuroim.2018.11.010","article-title":"Inhibitors of NF-\u03baB and P2X7\/NLRP3\/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer\u2019s disease","volume":"326","author":"Thawkar","year":"2019","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0775","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.2147\/IJN.S200490","article-title":"Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics","volume":"14","author":"Tiwari","year":"2019","journal-title":"Int J Nanomed"},{"issue":"4","key":"10.1016\/j.neuroscience.2022.12.007_b0780","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative Stress, Synaptic Dysfunction, and Alzheimer\u2019s Disease","volume":"57","author":"T\u00f6nnies","year":"2017","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.12.007_b0785","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1523\/JNEUROSCI.4111-08.2009","article-title":"Adenosine A(1) and A(2A) receptors in mouse prefrontal cortex modulate acetylcholine release and behavioral arousal","volume":"29","author":"Van Dort","year":"2009","journal-title":"J Neurosci: Off J Soc Neurosci"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.12.007_b0790","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12017-009-8073-2","article-title":"Amyloid-\u03b2 induces a caspase-mediated cleavage of P2X4 to promote purinotoxicity","volume":"11","author":"Varma","year":"2009","journal-title":"NeuroMol Med"},{"issue":"5","key":"10.1016\/j.neuroscience.2022.12.007_b0795","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.neuron.2007.05.018","article-title":"Caspase-3 cleavage of GGA3 stabilizes BACE: implications for Alzheimer\u2019s disease","volume":"54","author":"Vassar","year":"2007","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.12.007_b0800","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/tmi.13383","article-title":"The COVID-19 epidemic","volume":"25","author":"Velavan","year":"2020","journal-title":"Trop Med Int Health"},{"issue":"2","key":"10.1016\/j.neuroscience.2022.12.007_b0805","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1590\/S0101-60832010000200007","article-title":"Sistema colin\u00e9rgico: revisitando receptores, regula\u00e7\u00e3o e a rela\u00e7\u00e3o com a doen\u00e7a de Alzheimer, esquizofrenia, epilepsia e tabagismo","volume":"37","author":"Ventura","year":"2010","journal-title":"Archiv Clin Psychiatry (S\u00e3o Paulo)"},{"issue":"6","key":"10.1016\/j.neuroscience.2022.12.007_b0810","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1124\/mol.64.6.1309","article-title":"Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice","volume":"64","author":"Volpicelli-Daley","year":"2003","journal-title":"Mol Pharmacol"},{"issue":"7","key":"10.1016\/j.neuroscience.2022.12.007_b0815","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.bcp.2004.12.015","article-title":"Emerging prospects for the disease-modifying treatment of Alzheimer\u2019s disease","volume":"69","author":"Walker","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0820","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuropharm.2014.06.029","article-title":"Chronic caffeine treatment protects against experimental autoimmune encephalomyelitis in mice: therapeutic window and receptor subtype mechanism","volume":"86","author":"Wang","year":"2014","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.neuroscience.2022.12.007_b0825","first-page":"136","article-title":"Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease","volume":"3","author":"Wang","year":"2015","journal-title":"Ann Translat Med"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0830","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jchromb.2017.12.011","article-title":"Measurement of 8-oxo-7,8-dihydro-2\u2019-deoxyguanosine and 8-oxo-7,8-dihydro-guanosine in cerebrospinal fluid by ultra performance liquid chromatography-tandem mass spectrometry","volume":"1073","author":"Weimann","year":"2018","journal-title":"J Chromatogr B, Anal Technol Biomed Life Sci"},{"issue":"4","key":"10.1016\/j.neuroscience.2022.12.007_b0835","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/MMBR.69.4.635-664.2005","article-title":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus","volume":"69","author":"Weiss","year":"2005","journal-title":"Microbiol Mol Biol Rev: MMBR"},{"issue":"6","key":"10.1016\/j.neuroscience.2022.12.007_b0840","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.cell.2020.10.029","article-title":"Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer\u2019s Disease","volume":"183","author":"Wesseling","year":"2020","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.neuroscience.2022.12.007_b0845","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/alz.12164","article-title":"Cognitive outcomes in trials of two BACE inhibitors in Alzheimer\u2019s disease","volume":"16","author":"Wessels","year":"2020","journal-title":"Alzheimer\u2019s Dementia: J Alzheimer\u2019s Assoc"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0850","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neurobiolaging.2021.08.012","article-title":"Relationship of APOE, age at onset, amyloid and clinical phenotype in Alzheimer disease","volume":"108","author":"Whitwell","year":"2021","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.12.007_b0855","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11064-018-2511-1","article-title":"Dysfunctional \u03b3-secretase in familial Alzheimer\u2019s disease","volume":"44","author":"Wolfe","year":"2019","journal-title":"Neurochem Res"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0860","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuropharm.2015.10.031","article-title":"Purinergic receptors as potential therapeutic targets in Alzheimer\u2019s disease","volume":"104","author":"Woods","year":"2016","journal-title":"Neuropharmacology"},{"issue":"6483","key":"10.1016\/j.neuroscience.2022.12.007_b0865","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0870","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbi.2020.03.031","article-title":"Nervous system involvement after infection with COVID-19 and other coronaviruses","volume":"87","author":"Wu","year":"2020","journal-title":"Brain Behav Immunity"},{"issue":"1","key":"10.1016\/j.neuroscience.2022.12.007_b0875","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-021-00237-2","article-title":"COVID-19 and Alzheimer\u2019s disease: how one crisis worsens the other","volume":"10","author":"Xia","year":"2021","journal-title":"Translat Neurodegenerat"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0880","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuro.2020.07.003","article-title":"Multifunctional roles of zinc in Alzheimer\u2019s disease","volume":"80","author":"Xie","year":"2020","journal-title":"Neurotoxicology"},{"issue":"13","key":"10.1016\/j.neuroscience.2022.12.007_b0885","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139834","article-title":"Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease","volume":"5","author":"Zhao","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.neuroscience.2022.12.007_b0890","article-title":"Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov","author":"Zhao","year":"2020","journal-title":"bioRxiv"},{"issue":"12","key":"10.1016\/j.neuroscience.2022.12.007_b0895","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/cells7120229","article-title":"Mitochondrial Metabolism in Major Neurological Diseases","volume":"7","author":"Zhou","year":"2018","journal-title":"Cells"},{"issue":"7798","key":"10.1016\/j.neuroscience.2022.12.007_b0900","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"Pt 9","key":"10.1016\/j.neuroscience.2022.12.007_b0905","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awt210","article-title":"Inflammatory components in human Alzheimer\u2019s disease and after active amyloid-\u03b242 immunization","volume":"136","author":"Zotova","year":"2013","journal-title":"Brain J Neurol"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452222006157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452222006157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:16:58Z","timestamp":1759681018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452222006157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":184,"alternative-id":["S0306452222006157"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2022.12.007","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Action of the Purinergic and Cholinergic Anti-inflammatory Pathways on Oxidative Stress in Patients with Alzheimer\u2019s Disease in the Context of the COVID-19 Pandemic","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2022.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 IBRO. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}